Global Neuroblastoma Treatment Drugs Supply, Demand and Key Producers, 2023-2029

Page: 104

Published Date: 20 Feb 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

The global Neuroblastoma Treatment Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Neuroblastoma (NB) is the most common cancer in childhood and infancy. Most children with neuroblastoma are diagnosed before age 5 and symptoms can range from a painless bump in the abdomen to fevers and limp. Neuroblastoma treatment depends on multiple factors, including the patient's age, whether the tumor has already spread beyond its initial location and the risk of the tumor growing or spreading in the future.

This report studies the global Neuroblastoma Treatment Drugs production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Neuroblastoma Treatment Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Neuroblastoma Treatment Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Neuroblastoma Treatment Drugs total production and demand, 2018-2029, (K Units)
Global Neuroblastoma Treatment Drugs total production value, 2018-2029, (USD Million)
Global Neuroblastoma Treatment Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Neuroblastoma Treatment Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Neuroblastoma Treatment Drugs domestic production, consumption, key domestic manufacturers and share
Global Neuroblastoma Treatment Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Neuroblastoma Treatment Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Neuroblastoma Treatment Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Neuroblastoma Treatment Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include United Therapeutics, Y-mAbs Therapeutics, EUSA Pharma, ANI Pharmaceuticals, Baxter Healthcare, Ingenus Pharmaceuticals, Pfizer, Hikma Pharmaceuticals and Teva Pharmaceuticals, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Neuroblastoma Treatment Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Neuroblastoma Treatment Drugs Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Neuroblastoma Treatment Drugs Market, Segmentation by Type
    Cyclophosphamide
    Dinutuximab
    Naxitamab
    Doxorubicin Hydrochloride
    Vincristine Sulfate
    Other

Global Neuroblastoma Treatment Drugs Market, Segmentation by Application
    Hospital
    Clinic
    Other

Companies Profiled:
    United Therapeutics
    Y-mAbs Therapeutics
    EUSA Pharma
    ANI Pharmaceuticals
    Baxter Healthcare
    Ingenus Pharmaceuticals
    Pfizer
    Hikma Pharmaceuticals
    Teva Pharmaceuticals

Key Questions Answered
1. How big is the global Neuroblastoma Treatment Drugs market?
2. What is the demand of the global Neuroblastoma Treatment Drugs market?
3. What is the year over year growth of the global Neuroblastoma Treatment Drugs market?
4. What is the production and production value of the global Neuroblastoma Treatment Drugs market?
5. Who are the key producers in the global Neuroblastoma Treatment Drugs market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Neuroblastoma Treatment Drugs Introduction
    1.2 World Neuroblastoma Treatment Drugs Supply & Forecast
        1.2.1 World Neuroblastoma Treatment Drugs Production Value (2018 & 2022 & 2029)
        1.2.2 World Neuroblastoma Treatment Drugs Production (2018-2029)
        1.2.3 World Neuroblastoma Treatment Drugs Pricing Trends (2018-2029)
    1.3 World Neuroblastoma Treatment Drugs Production by Region (Based on Production Site)
        1.3.1 World Neuroblastoma Treatment Drugs Production Value by Region (2018-2029)
        1.3.2 World Neuroblastoma Treatment Drugs Production by Region (2018-2029)
        1.3.3 World Neuroblastoma Treatment Drugs Average Price by Region (2018-2029)
        1.3.4 North America Neuroblastoma Treatment Drugs Production (2018-2029)
        1.3.5 Europe Neuroblastoma Treatment Drugs Production (2018-2029)
        1.3.6 China Neuroblastoma Treatment Drugs Production (2018-2029)
        1.3.7 Japan Neuroblastoma Treatment Drugs Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Neuroblastoma Treatment Drugs Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Neuroblastoma Treatment Drugs Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Neuroblastoma Treatment Drugs Demand (2018-2029)
    2.2 World Neuroblastoma Treatment Drugs Consumption by Region
        2.2.1 World Neuroblastoma Treatment Drugs Consumption by Region (2018-2023)
        2.2.2 World Neuroblastoma Treatment Drugs Consumption Forecast by Region (2024-2029)
    2.3 United States Neuroblastoma Treatment Drugs Consumption (2018-2029)
    2.4 China Neuroblastoma Treatment Drugs Consumption (2018-2029)
    2.5 Europe Neuroblastoma Treatment Drugs Consumption (2018-2029)
    2.6 Japan Neuroblastoma Treatment Drugs Consumption (2018-2029)
    2.7 South Korea Neuroblastoma Treatment Drugs Consumption (2018-2029)
    2.8 ASEAN Neuroblastoma Treatment Drugs Consumption (2018-2029)
    2.9 India Neuroblastoma Treatment Drugs Consumption (2018-2029)

3 World Neuroblastoma Treatment Drugs Manufacturers Competitive Analysis
    3.1 World Neuroblastoma Treatment Drugs Production Value by Manufacturer (2018-2023)
    3.2 World Neuroblastoma Treatment Drugs Production by Manufacturer (2018-2023)
    3.3 World Neuroblastoma Treatment Drugs Average Price by Manufacturer (2018-2023)
    3.4 Neuroblastoma Treatment Drugs Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Neuroblastoma Treatment Drugs Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Neuroblastoma Treatment Drugs in 2022
        3.5.3 Global Concentration Ratios (CR8) for Neuroblastoma Treatment Drugs in 2022
    3.6 Neuroblastoma Treatment Drugs Market: Overall Company Footprint Analysis
        3.6.1 Neuroblastoma Treatment Drugs Market: Region Footprint
        3.6.2 Neuroblastoma Treatment Drugs Market: Company Product Type Footprint
        3.6.3 Neuroblastoma Treatment Drugs Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Neuroblastoma Treatment Drugs Production Value Comparison
        4.1.1 United States VS China: Neuroblastoma Treatment Drugs Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Neuroblastoma Treatment Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Neuroblastoma Treatment Drugs Production Comparison
        4.2.1 United States VS China: Neuroblastoma Treatment Drugs Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Neuroblastoma Treatment Drugs Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Neuroblastoma Treatment Drugs Consumption Comparison
        4.3.1 United States VS China: Neuroblastoma Treatment Drugs Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Neuroblastoma Treatment Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Neuroblastoma Treatment Drugs Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Neuroblastoma Treatment Drugs Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Neuroblastoma Treatment Drugs Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Neuroblastoma Treatment Drugs Production (2018-2023)
    4.5 China Based Neuroblastoma Treatment Drugs Manufacturers and Market Share
        4.5.1 China Based Neuroblastoma Treatment Drugs Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Neuroblastoma Treatment Drugs Production Value (2018-2023)
        4.5.3 China Based Manufacturers Neuroblastoma Treatment Drugs Production (2018-2023)
    4.6 Rest of World Based Neuroblastoma Treatment Drugs Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Neuroblastoma Treatment Drugs Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Neuroblastoma Treatment Drugs Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Neuroblastoma Treatment Drugs Production (2018-2023)

5 Market Analysis by Type
    5.1 World Neuroblastoma Treatment Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Cyclophosphamide
        5.2.2 Dinutuximab
        5.2.3 Naxitamab
        5.2.4 Doxorubicin Hydrochloride
        5.2.5 Vincristine Sulfate
        5.2.6 Other
    5.3 Market Segment by Type
        5.3.1 World Neuroblastoma Treatment Drugs Production by Type (2018-2029)
        5.3.2 World Neuroblastoma Treatment Drugs Production Value by Type (2018-2029)
        5.3.3 World Neuroblastoma Treatment Drugs Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Neuroblastoma Treatment Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Clinic
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World Neuroblastoma Treatment Drugs Production by Application (2018-2029)
        6.3.2 World Neuroblastoma Treatment Drugs Production Value by Application (2018-2029)
        6.3.3 World Neuroblastoma Treatment Drugs Average Price by Application (2018-2029)

7 Company Profiles
    7.1 United Therapeutics
        7.1.1 United Therapeutics Details
        7.1.2 United Therapeutics Major Business
        7.1.3 United Therapeutics Neuroblastoma Treatment Drugs Product and Services
        7.1.4 United Therapeutics Neuroblastoma Treatment Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 United Therapeutics Recent Developments/Updates
        7.1.6 United Therapeutics Competitive Strengths & Weaknesses
    7.2 Y-mAbs Therapeutics
        7.2.1 Y-mAbs Therapeutics Details
        7.2.2 Y-mAbs Therapeutics Major Business
        7.2.3 Y-mAbs Therapeutics Neuroblastoma Treatment Drugs Product and Services
        7.2.4 Y-mAbs Therapeutics Neuroblastoma Treatment Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Y-mAbs Therapeutics Recent Developments/Updates
        7.2.6 Y-mAbs Therapeutics Competitive Strengths & Weaknesses
    7.3 EUSA Pharma
        7.3.1 EUSA Pharma Details
        7.3.2 EUSA Pharma Major Business
        7.3.3 EUSA Pharma Neuroblastoma Treatment Drugs Product and Services
        7.3.4 EUSA Pharma Neuroblastoma Treatment Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 EUSA Pharma Recent Developments/Updates
        7.3.6 EUSA Pharma Competitive Strengths & Weaknesses
    7.4 ANI Pharmaceuticals
        7.4.1 ANI Pharmaceuticals Details
        7.4.2 ANI Pharmaceuticals Major Business
        7.4.3 ANI Pharmaceuticals Neuroblastoma Treatment Drugs Product and Services
        7.4.4 ANI Pharmaceuticals Neuroblastoma Treatment Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 ANI Pharmaceuticals Recent Developments/Updates
        7.4.6 ANI Pharmaceuticals Competitive Strengths & Weaknesses
    7.5 Baxter Healthcare
        7.5.1 Baxter Healthcare Details
        7.5.2 Baxter Healthcare Major Business
        7.5.3 Baxter Healthcare Neuroblastoma Treatment Drugs Product and Services
        7.5.4 Baxter Healthcare Neuroblastoma Treatment Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Baxter Healthcare Recent Developments/Updates
        7.5.6 Baxter Healthcare Competitive Strengths & Weaknesses
    7.6 Ingenus Pharmaceuticals
        7.6.1 Ingenus Pharmaceuticals Details
        7.6.2 Ingenus Pharmaceuticals Major Business
        7.6.3 Ingenus Pharmaceuticals Neuroblastoma Treatment Drugs Product and Services
        7.6.4 Ingenus Pharmaceuticals Neuroblastoma Treatment Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Ingenus Pharmaceuticals Recent Developments/Updates
        7.6.6 Ingenus Pharmaceuticals Competitive Strengths & Weaknesses
    7.7 Pfizer
        7.7.1 Pfizer Details
        7.7.2 Pfizer Major Business
        7.7.3 Pfizer Neuroblastoma Treatment Drugs Product and Services
        7.7.4 Pfizer Neuroblastoma Treatment Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Pfizer Recent Developments/Updates
        7.7.6 Pfizer Competitive Strengths & Weaknesses
    7.8 Hikma Pharmaceuticals
        7.8.1 Hikma Pharmaceuticals Details
        7.8.2 Hikma Pharmaceuticals Major Business
        7.8.3 Hikma Pharmaceuticals Neuroblastoma Treatment Drugs Product and Services
        7.8.4 Hikma Pharmaceuticals Neuroblastoma Treatment Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Hikma Pharmaceuticals Recent Developments/Updates
        7.8.6 Hikma Pharmaceuticals Competitive Strengths & Weaknesses
    7.9 Teva Pharmaceuticals
        7.9.1 Teva Pharmaceuticals Details
        7.9.2 Teva Pharmaceuticals Major Business
        7.9.3 Teva Pharmaceuticals Neuroblastoma Treatment Drugs Product and Services
        7.9.4 Teva Pharmaceuticals Neuroblastoma Treatment Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Teva Pharmaceuticals Recent Developments/Updates
        7.9.6 Teva Pharmaceuticals Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Neuroblastoma Treatment Drugs Industry Chain
    8.2 Neuroblastoma Treatment Drugs Upstream Analysis
        8.2.1 Neuroblastoma Treatment Drugs Core Raw Materials
        8.2.2 Main Manufacturers of Neuroblastoma Treatment Drugs Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Neuroblastoma Treatment Drugs Production Mode
    8.6 Neuroblastoma Treatment Drugs Procurement Model
    8.7 Neuroblastoma Treatment Drugs Industry Sales Model and Sales Channels
        8.7.1 Neuroblastoma Treatment Drugs Sales Model
        8.7.2 Neuroblastoma Treatment Drugs Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Neuroblastoma Treatment Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Neuroblastoma Treatment Drugs Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Neuroblastoma Treatment Drugs Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Neuroblastoma Treatment Drugs Production Value Market Share by Region (2018-2023)
    Table 5. World Neuroblastoma Treatment Drugs Production Value Market Share by Region (2024-2029)
    Table 6. World Neuroblastoma Treatment Drugs Production by Region (2018-2023) & (K Units)
    Table 7. World Neuroblastoma Treatment Drugs Production by Region (2024-2029) & (K Units)
    Table 8. World Neuroblastoma Treatment Drugs Production Market Share by Region (2018-2023)
    Table 9. World Neuroblastoma Treatment Drugs Production Market Share by Region (2024-2029)
    Table 10. World Neuroblastoma Treatment Drugs Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Neuroblastoma Treatment Drugs Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Neuroblastoma Treatment Drugs Major Market Trends
    Table 13. World Neuroblastoma Treatment Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Neuroblastoma Treatment Drugs Consumption by Region (2018-2023) & (K Units)
    Table 15. World Neuroblastoma Treatment Drugs Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Neuroblastoma Treatment Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Neuroblastoma Treatment Drugs Producers in 2022
    Table 18. World Neuroblastoma Treatment Drugs Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Neuroblastoma Treatment Drugs Producers in 2022
    Table 20. World Neuroblastoma Treatment Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Neuroblastoma Treatment Drugs Company Evaluation Quadrant
    Table 22. World Neuroblastoma Treatment Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Neuroblastoma Treatment Drugs Production Site of Key Manufacturer
    Table 24. Neuroblastoma Treatment Drugs Market: Company Product Type Footprint
    Table 25. Neuroblastoma Treatment Drugs Market: Company Product Application Footprint
    Table 26. Neuroblastoma Treatment Drugs Competitive Factors
    Table 27. Neuroblastoma Treatment Drugs New Entrant and Capacity Expansion Plans
    Table 28. Neuroblastoma Treatment Drugs Mergers & Acquisitions Activity
    Table 29. United States VS China Neuroblastoma Treatment Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Neuroblastoma Treatment Drugs Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Neuroblastoma Treatment Drugs Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Neuroblastoma Treatment Drugs Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Neuroblastoma Treatment Drugs Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Neuroblastoma Treatment Drugs Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Neuroblastoma Treatment Drugs Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Neuroblastoma Treatment Drugs Production Market Share (2018-2023)
    Table 37. China Based Neuroblastoma Treatment Drugs Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Neuroblastoma Treatment Drugs Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Neuroblastoma Treatment Drugs Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Neuroblastoma Treatment Drugs Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Neuroblastoma Treatment Drugs Production Market Share (2018-2023)
    Table 42. Rest of World Based Neuroblastoma Treatment Drugs Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Neuroblastoma Treatment Drugs Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Neuroblastoma Treatment Drugs Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Neuroblastoma Treatment Drugs Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Neuroblastoma Treatment Drugs Production Market Share (2018-2023)
    Table 47. World Neuroblastoma Treatment Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Neuroblastoma Treatment Drugs Production by Type (2018-2023) & (K Units)
    Table 49. World Neuroblastoma Treatment Drugs Production by Type (2024-2029) & (K Units)
    Table 50. World Neuroblastoma Treatment Drugs Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Neuroblastoma Treatment Drugs Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Neuroblastoma Treatment Drugs Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Neuroblastoma Treatment Drugs Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Neuroblastoma Treatment Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Neuroblastoma Treatment Drugs Production by Application (2018-2023) & (K Units)
    Table 56. World Neuroblastoma Treatment Drugs Production by Application (2024-2029) & (K Units)
    Table 57. World Neuroblastoma Treatment Drugs Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Neuroblastoma Treatment Drugs Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Neuroblastoma Treatment Drugs Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Neuroblastoma Treatment Drugs Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. United Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 62. United Therapeutics Major Business
    Table 63. United Therapeutics Neuroblastoma Treatment Drugs Product and Services
    Table 64. United Therapeutics Neuroblastoma Treatment Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. United Therapeutics Recent Developments/Updates
    Table 66. United Therapeutics Competitive Strengths & Weaknesses
    Table 67. Y-mAbs Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 68. Y-mAbs Therapeutics Major Business
    Table 69. Y-mAbs Therapeutics Neuroblastoma Treatment Drugs Product and Services
    Table 70. Y-mAbs Therapeutics Neuroblastoma Treatment Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Y-mAbs Therapeutics Recent Developments/Updates
    Table 72. Y-mAbs Therapeutics Competitive Strengths & Weaknesses
    Table 73. EUSA Pharma Basic Information, Manufacturing Base and Competitors
    Table 74. EUSA Pharma Major Business
    Table 75. EUSA Pharma Neuroblastoma Treatment Drugs Product and Services
    Table 76. EUSA Pharma Neuroblastoma Treatment Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. EUSA Pharma Recent Developments/Updates
    Table 78. EUSA Pharma Competitive Strengths & Weaknesses
    Table 79. ANI Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 80. ANI Pharmaceuticals Major Business
    Table 81. ANI Pharmaceuticals Neuroblastoma Treatment Drugs Product and Services
    Table 82. ANI Pharmaceuticals Neuroblastoma Treatment Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. ANI Pharmaceuticals Recent Developments/Updates
    Table 84. ANI Pharmaceuticals Competitive Strengths & Weaknesses
    Table 85. Baxter Healthcare Basic Information, Manufacturing Base and Competitors
    Table 86. Baxter Healthcare Major Business
    Table 87. Baxter Healthcare Neuroblastoma Treatment Drugs Product and Services
    Table 88. Baxter Healthcare Neuroblastoma Treatment Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Baxter Healthcare Recent Developments/Updates
    Table 90. Baxter Healthcare Competitive Strengths & Weaknesses
    Table 91. Ingenus Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 92. Ingenus Pharmaceuticals Major Business
    Table 93. Ingenus Pharmaceuticals Neuroblastoma Treatment Drugs Product and Services
    Table 94. Ingenus Pharmaceuticals Neuroblastoma Treatment Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Ingenus Pharmaceuticals Recent Developments/Updates
    Table 96. Ingenus Pharmaceuticals Competitive Strengths & Weaknesses
    Table 97. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 98. Pfizer Major Business
    Table 99. Pfizer Neuroblastoma Treatment Drugs Product and Services
    Table 100. Pfizer Neuroblastoma Treatment Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Pfizer Recent Developments/Updates
    Table 102. Pfizer Competitive Strengths & Weaknesses
    Table 103. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 104. Hikma Pharmaceuticals Major Business
    Table 105. Hikma Pharmaceuticals Neuroblastoma Treatment Drugs Product and Services
    Table 106. Hikma Pharmaceuticals Neuroblastoma Treatment Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Hikma Pharmaceuticals Recent Developments/Updates
    Table 108. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 109. Teva Pharmaceuticals Major Business
    Table 110. Teva Pharmaceuticals Neuroblastoma Treatment Drugs Product and Services
    Table 111. Teva Pharmaceuticals Neuroblastoma Treatment Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 112. Global Key Players of Neuroblastoma Treatment Drugs Upstream (Raw Materials)
    Table 113. Neuroblastoma Treatment Drugs Typical Customers
    Table 114. Neuroblastoma Treatment Drugs Typical Distributors
List of Figure
    Figure 1. Neuroblastoma Treatment Drugs Picture
    Figure 2. World Neuroblastoma Treatment Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Neuroblastoma Treatment Drugs Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Neuroblastoma Treatment Drugs Production (2018-2029) & (K Units)
    Figure 5. World Neuroblastoma Treatment Drugs Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Neuroblastoma Treatment Drugs Production Value Market Share by Region (2018-2029)
    Figure 7. World Neuroblastoma Treatment Drugs Production Market Share by Region (2018-2029)
    Figure 8. North America Neuroblastoma Treatment Drugs Production (2018-2029) & (K Units)
    Figure 9. Europe Neuroblastoma Treatment Drugs Production (2018-2029) & (K Units)
    Figure 10. China Neuroblastoma Treatment Drugs Production (2018-2029) & (K Units)
    Figure 11. Japan Neuroblastoma Treatment Drugs Production (2018-2029) & (K Units)
    Figure 12. Neuroblastoma Treatment Drugs Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Neuroblastoma Treatment Drugs Consumption (2018-2029) & (K Units)
    Figure 15. World Neuroblastoma Treatment Drugs Consumption Market Share by Region (2018-2029)
    Figure 16. United States Neuroblastoma Treatment Drugs Consumption (2018-2029) & (K Units)
    Figure 17. China Neuroblastoma Treatment Drugs Consumption (2018-2029) & (K Units)
    Figure 18. Europe Neuroblastoma Treatment Drugs Consumption (2018-2029) & (K Units)
    Figure 19. Japan Neuroblastoma Treatment Drugs Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Neuroblastoma Treatment Drugs Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Neuroblastoma Treatment Drugs Consumption (2018-2029) & (K Units)
    Figure 22. India Neuroblastoma Treatment Drugs Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Neuroblastoma Treatment Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Neuroblastoma Treatment Drugs Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Neuroblastoma Treatment Drugs Markets in 2022
    Figure 26. United States VS China: Neuroblastoma Treatment Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Neuroblastoma Treatment Drugs Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Neuroblastoma Treatment Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Neuroblastoma Treatment Drugs Production Market Share 2022
    Figure 30. China Based Manufacturers Neuroblastoma Treatment Drugs Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Neuroblastoma Treatment Drugs Production Market Share 2022
    Figure 32. World Neuroblastoma Treatment Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Neuroblastoma Treatment Drugs Production Value Market Share by Type in 2022
    Figure 34. Cyclophosphamide
    Figure 35. Dinutuximab
    Figure 36. Naxitamab
    Figure 37. Doxorubicin Hydrochloride
    Figure 38. Vincristine Sulfate
    Figure 39. Other
    Figure 40. World Neuroblastoma Treatment Drugs Production Market Share by Type (2018-2029)
    Figure 41. World Neuroblastoma Treatment Drugs Production Value Market Share by Type (2018-2029)
    Figure 42. World Neuroblastoma Treatment Drugs Average Price by Type (2018-2029) & (US$/Unit)
    Figure 43. World Neuroblastoma Treatment Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 44. World Neuroblastoma Treatment Drugs Production Value Market Share by Application in 2022
    Figure 45. Hospital
    Figure 46. Clinic
    Figure 47. Other
    Figure 48. World Neuroblastoma Treatment Drugs Production Market Share by Application (2018-2029)
    Figure 49. World Neuroblastoma Treatment Drugs Production Value Market Share by Application (2018-2029)
    Figure 50. World Neuroblastoma Treatment Drugs Average Price by Application (2018-2029) & (US$/Unit)
    Figure 51. Neuroblastoma Treatment Drugs Industry Chain
    Figure 52. Neuroblastoma Treatment Drugs Procurement Model
    Figure 53. Neuroblastoma Treatment Drugs Sales Model
    Figure 54. Neuroblastoma Treatment Drugs Sales Channels, Direct Sales, and Distribution
    Figure 55. Methodology
    Figure 56. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Neuroblastoma Treatment Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Neuroblastoma Treatment Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 01 Jan 2023

date Pharma & Healthcare

Neuroblastoma (NB) is the most common cancer in childhood and infancy. Most children with neuroblastoma are diagnosed before age 5 and symptoms can range from a painless bump in the abdomen to fevers and limp. Neuroblastoma treatment depends on multiple factors, including the patient's age, whether the tumor has already spread beyond its initial location and the risk of the tumor growing or spreading in the future.

Global Neuroblastoma Treatment Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Neuroblastoma Treatment Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 09 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Neuroblastoma Treatment Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Neuroblastoma Treatment Drugs

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>